| Literature DB >> 23731504 |
Monica Monaco1, Palmino Pedroni, Andrea Sanchini, Annalisa Bonomini, Annamaria Indelicato, Annalisa Pantosti.
Abstract
BACKGROUND: Livestock-Associated MRSA (LA-MRSA) belonging to ST398 lineage, common among pigs and other animals, emerged in Central and Northern Europe, becoming a new risk factor for MRSA among farm workers. Strains belonging to ST398 can be responsible for human colonization and infection, mainly in areas with high livestock-farming. The aim of this study was to investigate the occurrence of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) human colonization and infections in an area of the Lombardy Region (Italy), the Italian region with the highest density of pig farming.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23731504 PMCID: PMC3679754 DOI: 10.1186/1471-2334-13-258
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1Density of breeding and fattening pigs in Italy. Adapted from [21]. The open circle indicates the area in the Lombardy Region where the study was performed.
Clinical informations, genotypic and phenotypic characteristics of MRSA responsible for human colonization and infections
| Colonization | | | | | | | | | | |
| Sau93 | M | 67 | - | IVc | t899 | 398 | 398 | - | - | ERY, CLI, SXT, TET |
| Sau95 | F | 77 | - | IVa | t899 | 398 | 398 | - | - | ERY, CLI, TET |
| Sau98 | F | 58 | - | IVa | t899 | 398 | 398 | - | - | TET |
| Sau91 | M | 40 | - | V | t108 | 398 | 398 | - | - | LVX #, TET |
| Sau99 | M | 20 | - | V | t2922 | 398 | 398 | - | - | ERY, CLI, SXT, TET |
| Sau96 | F | 61 | - | IVc | t008 | 8 | 8 | - | - | LVX, TET |
| Sau97 | M | 66 | - | IVc | t008 | 8 | 8 | - | - | GN, LVX |
| Sau92 | M | 71 | - | IVc | t008 | 8 | 8 | - | - | LVX |
| Sau94 | F | 17 | - | V | t688 | 5 | 5 | - | - | ERY, CLI*, TET |
| Infections | | | | | | | | | | |
| Sau150 | M | 18 | SSTI | IVa | t008 | 8 | 8 | + | + | LVX, ERY |
| Sau116 | F | 71 | SSTI | IVa | t008 | 8 | 8 | + | + | LVX, ERY |
| Sau161 | F | 27 | SSTI | IVa | t008 | 8 | 8 | + | + | LVX, ERY |
| Sau85 | F | 46 | SSTI | IVa | t121 | 8 | 8 | + | - | LVX, ERY |
| Sau86 | F | 35 | SSTI | IVc | t005 | 22 | 22 | + | - | ERY, CLI* |
| Sau149 | M | 0.8 | SSTI | IVc | t044 | 80 | 80 | + | - | FUS, TET |
| Sau151 | F | 2 | SSTI | V | t127 | 1 | 1 | + | - | GN, FUS, TET |
| Sau119 | M | 38 | SSTI | V | t7445 | 772 | 1 | + | - | GN, ERY, CLI* SXT, |
| Sau118 | F | 53 | SSTI | IVc | t008 | 8 | 8 | - | - | LVX #, |
| Sau73 | F | 70 | SSTI | IVc | t008 | 8 | 8 | - | - | LVX #, ERY, CLI* |
| Sau159 | F | 85 | SSTI | IVc | t008 | 8 | 8 | - | - | LVX |
| Sau163 | F | 53 | SSTI | IVc | t008 | 8 | 8 | - | - | GN, LVX, RIF |
| Sau84 | M | 67 | SSTI | IVc | t008 | 8 | 8 | - | - | LVX, TET |
| Sau121 | F | 83 | BSI | IVc | t008 | 8 | 8 | - | - | LVX |
| Sau82 | F | 84 | SSTI | IVa | t127 | 1 | 1 | - | - | LVX, ERY, CLI* |
| Sau83 | F | 9 | SSTI | IVa | t127 | 1 | 1 | - | - | ERY, CLI*, TET |
| Sau162 | F | 61 | OE | IVa | t127 | 1 | 1 | - | - | GN, ERY, CLI*, TET |
| Sau120 | M | 77 | SSTI | IVh | t515 | 22 | 22 | - | - | LVX # |
| Sau117 | M | 79 | SSTI | I | t041 | 228 | 5 | - | - | GN, LVX, ERY, CLI, RIF# |
| Sau74 | M | 68 | OE | IVc | t899 | 398 | 398 | - | - | CLI, SXT, TET |
SCCmec staphylococcal cassette chromosome mec, ST sequence type, CC clonal complex, PVL Panton-Valentine Leukocidin, ACME arginine catabolic mobile element.
§ GEN gentamicin, ERY erythromycin, CLI clindamycin, LVX levofloxacin, FUS fusidic acid, TET tetracycline, SXT co-trimoxazole, RIF rifampicin, * inducible clindamycin resistance; # intermediate resistance.
SSTI skin and soft tissue infection, BSI bloodstream infection, OE otitis externa.